际华集团8月8日发布公告，公司股票于2025年8月6日、8月7日、8月8日连续三个交易日收盘价格涨幅偏 离值累计达到20%，根据《上海证券交易所交易规则》的有关规定，属于股票交易异常波动情形。 经 核实，公司目前经营活动一切正常，内外部经营环境未发生重大变化。经公司自查并向公司控股股东新 兴际华集团有限公司核实：截至本公告披露之日，除了在指定媒体上已公开披露的信息外，公司及公司 控股股东不存在应予以披露而未披露的重大信息。公司于2025年8月8日收到中国证券监督管理委员会下 发的《立案告知书》，因公司涉嫌信息披露违法违规，根据《中华人民共和国证券法》《中华人民共和 国行政处罚法》等法律法规，中国证监会决定对公司立案。 ...

证券代码：601718 证券简称：际华集团 公告编号：临2025-039 际华集团股份有限公司 关于收到中国证券监督管理委员会立案告知书的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 际华集团股份有限公司（以下简称"公司"）于 2025 年 8 月 8 日收到中 国证券监督管理委员会（以下简称"中国证监会"）下发的《立案告知书》（证 监立案字 03720252003 号），因公司涉嫌信息披露违法违规，根据《中华人民 共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证监会决定对 公司立案。 目前公司各项经营活动和业务均正常开展，在立案调查期间，公司将积极配 合中国证监会的相关调查工作，并严格按有关法律法规等规定履行信息披露义务。 公司所有信息均以在上海证券交易所网站（www.sse.com.cn）和《中国证券报》 刊登的正式公告为准。 特此公告。 际华集团股份有限公司董事会 2025 年 8 月 9 日 ...

Group 1 - The company, Jihua Group (601718.SH), specializes in the research, production, and sales of workwear, work shoes, textile printing and dyeing, and protective equipment and gear [1] - As of now, the company's main business and existing product system do not involve the field of brain-computer interfaces [1]

Core Points - Jihua Group (601718) received a notice from the China Securities Regulatory Commission (CSRC) on August 8, indicating that the company is under investigation for suspected violations of information disclosure regulations [1] Summary by Category Company Announcement - On August 8, Jihua Group announced that it received a formal notice from the CSRC regarding an investigation into potential information disclosure violations [1] Regulatory Action - The CSRC has decided to initiate a case against Jihua Group due to the alleged violations, which may have implications for the company's operations and reputation in the market [1]

每经AI快讯，8月8日，际华集团（601718）(601718.SH)发布异动公告，公司主营业务为职业装、职业 鞋靴、纺织印染、防护装具及装备的研发、生产和销售。经核实，截至目前，公司主营业务及现有产品 体系未涉及脑机接口相关领域。 ...

Core Viewpoint - The brain-computer interface (BCI) sector is experiencing significant growth due to favorable government policies and advancements in technology, leading to increased market activity and investment opportunities [1][3]. Policy Support - The Ministry of Industry and Information Technology, along with six other departments, issued an implementation opinion aimed at promoting innovation in the BCI industry, setting construction goals for the next five years [3]. - By 2027, key technologies in BCI are expected to achieve breakthroughs, establishing an advanced technical, industrial, and standard system, with products reaching international advanced levels [3]. - By 2030, the BCI industry is anticipated to have a significantly enhanced innovation capability, fostering 2 to 3 globally influential leading enterprises and a number of specialized small and medium-sized enterprises [3]. Market Activity - Several companies in the BCI sector have seen substantial stock price increases, with notable gains including: - Jihua Group up 10% to 5.28 - Innovation Medical up 7.33% to 18.75 - Sanbo Brain Science up 9.51% to 59.78 - Botao Biology up 9.49% to 35.75 [1][2]. Insurance Integration - The National Medical Insurance Administration has standardized pricing for BCI-related procedures, such as "BCI implantation fees" and "BCI adaptation fees," facilitating quicker clinical application and reimbursement once the technology is approved [5][4]. Commercialization Outlook - The BCI technology is maturing, with the first BCI outpatient clinic in Central China operational and successful surgeries conducted [6]. - Analysts from Open Source Securities and Zheshang Securities express optimism about the commercialization of BCI technology, highlighting the rapid expansion of the market and encouraging attention to companies within the BCI supply chain [6]. - Key players in the upstream hardware and software sectors include Entropy Technology, iFlytek, and others, while downstream medical solution providers include Aipeng Medical, Xiangyu Medical, and others [6].

本报记者 许林艳 8月8日，脑机接口概念股进一步上涨。截至午间收盘，际华集团（601718）涨停，麦澜德涨停超10%， 三博脑科（301293）、乐普医疗（300003）涨超8%，爱朋医疗（300753）、诚益通（300430）等纷纷 跟涨。 福州公孙策公关咨询有限公司合伙人詹军豪表示，目前我国脑机接口技术已取得显著进展，非侵入式技 术在医疗康复等领域实现初步应用，侵入式技术也进入了临床试验阶段。 根据中国电子信息产业发展研究院数据，2024年中国脑机接口市场规模为32亿元，同比增长18.8%；预 计到2027年将达到55.8亿元。 多地均在积极推进脑机接口产业发展。今年年初，北京印发《加快北京市脑机接口创新发展行动方案 （2025-2030年）》，其中提出，到2030年打造1-2个脑机接口产业发展集聚示范区，实现脑机接口创新 产品在医疗、康养、工业、教育等领域的规模化商用。 同期，上海印发《上海市脑机接口未来产业培育行动方案（2025-2030年）》，其中提出2030年前，实 现高质量控脑，脑机接口产品全面实现临床应用，打造全球脑机接口产品创新高地，产业链核心环节实 现自主可控。 政策利好不断，脑机接口产业 ...

Core Viewpoint - The brain-computer interface (BCI) sector is experiencing significant growth driven by favorable government policies and technological advancements, with expectations for substantial market expansion in the coming years [1][4]. Group 1: Market Performance - On August 8, stocks related to the brain-computer interface concept surged, with notable gains including Beiyikang at 13% limit up and Sanbo Brain Science at over 11% [1]. - Other companies such as Innovation Medical and Jihua Group also reached their limit up, indicating strong market interest [1]. Group 2: Government Policies - The Ministry of Industry and Information Technology, along with six other departments, issued implementation opinions aimed at promoting innovation in the BCI industry, targeting breakthroughs in key technologies by 2027 [2]. - By 2030, the goal is to establish a reliable industrial system and cultivate globally influential leading enterprises within the BCI sector [2]. Group 3: Industry Insights - The National Medical Insurance Administration has introduced a pricing mechanism for newly launched drugs and medical devices, facilitating the commercialization of new technologies [3]. - Recent reports indicate that the BCI sector is accelerating its commercial transformation, with non-invasive applications in medical rehabilitation and emotional management gaining traction [4]. - The domestic BCI market is expected to expand rapidly, supported by favorable policies and advancements in technology [4].

Core Viewpoint - The article discusses the performance of the Chinese stock market on August 8, 2025, highlighting the slight gains in major indices and the active sectors, particularly in hydropower, stablecoins, commercial aerospace, innovative pharmaceuticals, and liquid cooling servers, while noting a pullback in sectors like PEEK materials, AI agents, semiconductors, and robotics [3][4]. Market Performance - The Shanghai Composite Index closed at 3642.1 points, up 0.07% - The Shenzhen Component Index closed at 11173.87 points, up 0.14% - The ChiNext Index closed at 2347.83 points, up 0.21% [3][4]. Capital Flow - Major capital inflows were observed in sectors such as machinery, electric power, non-ferrous metals, and pharmaceuticals, while outflows were noted in computer, electronics, media, food and beverage, and banking sectors [8]. - Specific stocks with significant net inflows included Yingweike (16.56 billion), Shanhe Intelligent (13.08 billion), and Jihua Group (12.84 billion) [8]. Trading Volume - The trading volume in the two markets exceeded 1 trillion yuan for the 52nd consecutive trading day [9]. Sector Highlights - The hydropower sector saw notable gains, with Shanhe Intelligent hitting the daily limit, and other related stocks like Sheyan Institute and Deep Water Planning Institute also performing well [10][13]. - The electric power sector experienced a rise, with Huaguang Huaneng and Huayin Electric reaching the daily limit [13]. Stock Movements - Stocks such as Innovation Medical and Jihua Group reached their daily limit, while other stocks in the medical device sector also saw significant increases [17][21]. - The gas sector showed a short-term rise, with Hongtong Gas achieving four consecutive limits [19]. Economic Indicators - The People's Bank of China conducted a 122 billion yuan reverse repurchase operation at a fixed rate of 1.40%, with a net withdrawal of 40 billion yuan for the day [25]. - The RMB to USD exchange rate was adjusted down by 37 basis points, reported at 7.1382 [26].

Group 1 - The core viewpoint of the news is the significant advancements expected in brain-computer interface (BCI) technology by 2027, with the establishment of an advanced technical, industrial, and standard system [1][3] - The Ministry of Industry and Information Technology, along with six other departments, has issued implementation opinions to promote innovation and development in the BCI industry, aiming for breakthroughs in key technologies and the establishment of a robust industrial ecosystem by 2030 [3] - The BCI market is projected to expand rapidly, driven by the increasing application of BCI products in various sectors such as industrial manufacturing, healthcare, and consumer life [3][4] Group 2 - Following positive news, several BCI-related stocks experienced significant price increases, with Beiyikang reaching a 13.57% rise and Sanbo Brain Science increasing by 11.69% [2] - The report from Founder Securities highlights the acceleration of commercial transformation in the BCI sector, particularly in non-invasive applications for medical rehabilitation and emotional management, indicating a broad market outlook [4] - Open Source Securities notes that the BCI technology landscape is undergoing rapid transformation, with upstream technological advancements leading to breakthroughs in downstream applications, suggesting a promising commercial future for domestic BCI companies [4]